May 19, 2020, 12pm EDT / 5pm BST
The science of viral vector manufacturing is generating a lot of excitement, but companies in this space are under pressure to move fast and make cost-effective decisions – which can occasionally result in speed at the expense of due diligence. Your facility should be capable of making the science happen smoothly and cost-effectively at a commercial scale, and the production environment should be designed for maximum efficiency. But the design of such a facility requires a close examination of assumptions and decisions.
Learning Objectives
This webinar will give viewers the tools they need to initiate a close examination of their methods.
Viewers can reach a more fulsome appreciation of the interdependent factors that contribute to efficient and reliable throughput of viral vector products at the commercial scale.
Newsletters
Receive the latest pharmaceutical news, personalities, education, and career development – weekly to your inbox.
